Novotech Malaysia has signed a Memorandum of Understanding with Clinical Research Malaysia (CRM) on 20th April 2018 to establish strategic partnerships in clinical research.

Other relevant content

November 27, 2023 News

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…

Read more Notification Icon
November 22, 2023 News

Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical…

Read more Notification Icon
November 14, 2023 News

Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

Read more Notification Icon
November 14, 2023 News

Navigating the Complexities of Planning and Executing Multiregional Clinical Trials

Read more Notification Icon
November 8, 2023 News

Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials…

Read more Notification Icon
November 6, 2023 News

Driving Progress Towards Gender Equality and Inclusion

Read more Notification Icon
November 7, 2023 News

Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials

Read more Notification Icon
November 6, 2023 News

Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary…

Read more Notification Icon
October 13, 2023 News

Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva…

Read more Notification Icon
October 5, 2023 News

Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services

Read more Notification Icon
October 13, 2023 News

Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr…

Read more Notification Icon
October 11, 2023 News

Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award

Read more Notification Icon